Tocriscreen FDA-Approved Drugs Library
Biological ActivityTocriscreen FDA-Approved Drugs Library is a library of 190 compounds equivalent to the pharmacologically active components of drug formulations approved by the FDA. Compounds supplied pre-dissolved in DMSO (100 μL, 10 mM solution). Contains compounds covering a diverse range of pharmaceutical targets and therapeutic areas e.g. immunology, oncology. Includes both established therapeutics, e.g. tamoxifen (Cat. No. 0999) & paclitaxel (Cat. No. 1097), as well as more recently approved drugs such as darunavir (Cat. No. 6710) & sorafenib (Cat. No. 6814). Ideal for in vitro and in vivo drug repurposing/repositioning studies.
This library replaces the Tocriscreen Library of FDA-Approved Compounds (Cat. No. 5932).
All Tocris products are for biomedical research use only. They are not intended for human or veterinary use.
For more information about this compound library, please download our informative flyer.
Key Format and Product Details
- All compounds are equivalent to active components of FDA-approved drug formulations
- Full chemical and biological data available in Excell and SD file formats
- 96-well racks with Matrix storage tubes & SepraSeal caps
- Compounds arranged with a maximum of 80 per rack with 3 racks per library
- Pre-dissolved in 100 μL 10 mM DMSO solutions
- Compounds produced to same high chemical standard as Tocris catalog
The Tocriscreen FDA-approved Drugs Library contains bioactive compounds covering a diverse range of therapeutic classifications, derived using the WHO Anatomical Therapeutic Chemical Classification System code (ATC code).
Request Compound List
A list of the compounds available in the Tocriscreen FDA-Approved Drugs Library can be requested in Excel or SD format via our Tocriscreen & Custom Library Inquiries form.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Complete Your Research
The University of New Mexico Center for Molecular Discovery.
Edwards et al.
Comb.Chem.High Throughput Screen., 2014;17:256
Small-molecule-driven direct reprogramming of mouse fibroblasts into functional neurons.
Li et al.
Cell Stem Cell, 2015;17:195
Citations for Tocriscreen FDA-Approved Drugs Library
The citations listed below are publications that use Tocris products. Selected citations for Tocriscreen FDA-Approved Drugs Library include:
4 Citations: Showing 1 - 4
Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles.
Authors: Edmister Et al.
Screening of chemical libraries using xenopus embryos and tadpoles for phenotypic drug discovery.
Authors: Gull Et al.
Cold Spring Harb.Protoc. 2022;
Using in silico modelling and FRET-based assays in the discovery of novel FDA-approved drugs as inhibitors of MERS-CoV helicase.
Authors: Mehyar Et al.
SAR QSAR Environ Res 2020;6:1
Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro.
Authors: Shin Et al.
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for Tocriscreen FDA-Approved Drugs Library
There are currently no reviews for this product. Be the first to review Tocriscreen FDA-Approved Drugs Library and earn rewards!
Have you used Tocriscreen FDA-Approved Drugs Library?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image